1. Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT.
- Author
-
Das, Marco, Mühlenbruch, Georg, Mahnken, Andreas H., Hering, K., Sirbu, H., Zschiesche, W., Knoll, Lars, Felten, Michael K., Kraus, Thomas, Günther, Rolf W., Wildberger, Joachim E., Mühlenbruch, Georg, Hering, K G, and Günther, Rolf W
- Subjects
ASBESTOS & the environment ,ASBESTOS -- Risk factors ,CANCER education ,LUNG cancer ,MEDICAL radiography ,RADIATION ,COMPUTED tomography ,COMPUTER software ,DIAGNOSTIC imaging ,LONGITUDINAL method ,DUST diseases ,LUNG tumors ,COMPUTERS in medicine ,MESOTHELIOMA ,POWER plants ,PUBLIC health surveillance ,RISK assessment ,TIME ,OCCUPATIONAL hazards ,ENVIRONMENTAL exposure ,DISEASE prevalence - Abstract
The purpose of this study was to assess the prevalence of lung cancer in a high-risk asbestos-exposed cohort using low-dose MDCT. Of a population of 5,389 former power-plant workers, 316 were characterized as individuals at highest risk for lung cancer according to a lung-cancer risk model including age, asbestos exposure and smoking habits. Of these 316, 187 (mean age: 66.6 years) individuals were included in a prospective trial. Mean asbestos exposure time was 29.65 years and 89% were smokers. Screening was performed on a 16-slice MDCT (Siemens) with low-dose technique (10/20 mAs(eff.); 1 mm/0.5 mm increment). In addition to soft copy PACS reading analysis on a workstation with a dedicated lung analysis software (LungCARE; Siemens) was performed. One strongly suspicious mass and eight cases of histologically proven lung cancer were found plus 491 additional pulmonary nodules (average volume: 40.72 ml, average diameter 4.62 mm). Asbestos-related changes (pleural plaques, fibrosis) were visible in 80 individuals. Lung cancer screening in this high-risk cohort showed a prevalence of lung cancer of 4.28% (8/187) at baseline screening with an additional large number of indeterminate pulmonary nodules. Low-dose MDCT proved to be feasible in this highly selected population. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF